Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
Want to see TRVI full AI Analyst Report?
TRVI Analyst Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TRVI Stock 12 Month Forecast
Average Price Target
$24.50
▲(81.89% Upside)
| Highest Price Target$30.00 | Average Price Target$24.50 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Stifel Nicolaus
$18→$30
Buy
122.72%
Upside
Assigned
05/08/26
Oppenheimer
$24
Buy
78.17%
Upside
Reiterated
05/08/26
H.C. Wainwright
$21
Buy
55.90%
Upside
Reiterated
05/08/26
Clear Street
$21→$29
Buy
115.29%
Upside
Reiterated
05/07/26
JonesTrading
$24
Buy
78.17%
Upside
Reiterated
05/06/26
Needham
$23
Buy
70.75%
Upside
Reiterated
05/06/26
Morgan Stanley
$18→$20
Buy
48.48%
Upside
Assigned
05/05/26
Cantor Fitzgerald
$25
Buy
85.60%
Upside
Reiterated
03/17/26
Leerink Partners
$13→$16
Buy
18.78%
Upside
Reiterated
11/18/25
Jefferies
―
Buy
―
Reiterated
09/29/25
B. Riley Securities
$20→$16
Buy
18.78%
Upside
Reiterated
08/14/25
Raymond James
$29→$27
Buy
100.45%
Upside
Reiterated
08/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
$18→$30
Buy
122.72%
Upside
Assigned
05/08/26
Oppenheimer
$24
Buy
78.17%
Upside
Reiterated
05/08/26
H.C. Wainwright
$21
Buy
55.90%
Upside
Reiterated
05/08/26
Clear Street
$21→$29
Buy
115.29%
Upside
Reiterated
05/07/26
JonesTrading
$24
Buy
78.17%
Upside
Reiterated
05/06/26
Needham
$23
Buy
70.75%
Upside
Reiterated
05/06/26
Morgan Stanley
$18→$20
Buy
48.48%
Upside
Assigned
05/05/26
Cantor Fitzgerald
$25
Buy
85.60%
Upside
Reiterated
03/17/26
Leerink Partners
$13→$16
Buy
18.78%
Upside
Reiterated
11/18/25
Jefferies
―
Buy
―
Reiterated
09/29/25
B. Riley Securities
$20→$16
Buy
18.78%
Upside
Reiterated
08/14/25
Raymond James
$29→$27
Buy
100.45%
Upside
Reiterated
08/08/25
Best Analysts Covering Trevi Therapeutics
3 Months
xxx
Success Rate
12/13 ratings generated profit
Average Return
+28.90%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 92.31% of your transactions generating a profit, with an average return of +28.90% per trade.
1 Year
Success Rate
13/13 ratings generated profit
Average Return
+139.44%
Copying Debanjana Chatterjee's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +139.44% per trade.
2 Years
xxx
Success Rate
18/18 ratings generated profit
Average Return
+298.67%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +298.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TRVI Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
9
3
14
13
17
Buy
3
1
1
1
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
4
15
14
20
Each month's total comprises the sum of three months' worth of ratings.
TRVI Financial Forecast
TRVI Stock Forecast FAQ
What is TRVI’s average 12-month price target, according to analysts?
Based on analyst ratings, Trevi Therapeutics Inc’s 12-month average price target is 24.50.
What is TRVI’s upside potential, based on the analysts’ average price target?
Trevi Therapeutics Inc has 81.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TRVI a Buy, Sell or Hold?
Trevi Therapeutics Inc has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
What is Trevi Therapeutics Inc’s price target?
The average price target for Trevi Therapeutics Inc is 24.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $20.00. The average price target represents 81.89% Increase from the current price of $13.47.
The highest analyst price target is $30.00 ,the lowest forecast is $20.00. The average price target represents 81.89% Increase from the current price of $13.47.
What do analysts say about Trevi Therapeutics Inc?
Trevi Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of TRVI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.